Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Debt Ratio (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Debt Ratio for 9 consecutive years, with 0.17 as the latest value for Q4 2025.

  • On a quarterly basis, Debt Ratio rose 340.33% to 0.17 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.17, a 340.33% increase, with the full-year FY2025 number at 0.17, up 340.33% from a year prior.
  • Debt Ratio was 0.17 for Q4 2025 at Myriad Genetics, up from 0.16 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.17 in Q4 2025 to a low of 0.03 in Q2 2023.
  • A 4-year average of 0.07 and a median of 0.04 in 2024 define the central range for Debt Ratio.
  • Peak YoY movement for Debt Ratio: skyrocketed 3367.42% in 2021, then increased 7.65% in 2024.
  • Myriad Genetics' Debt Ratio stood at 0.08 in 2021, then plummeted by 56.12% to 0.03 in 2023, then increased by 14.76% to 0.04 in 2024, then surged by 340.33% to 0.17 in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Debt Ratio are 0.17 (Q4 2025), 0.16 (Q3 2025), and 0.09 (Q2 2025).